tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CEL-SCI 2M share Spot Secondary priced at $2.50
PremiumThe FlyCEL-SCI 2M share Spot Secondary priced at $2.50
2M ago
CEL-SCI announces common stock offering, no amount given
Premium
The Fly
CEL-SCI announces common stock offering, no amount given
2M ago
CEL-SCI completes Breakthrough Medicine Designation application for Multikine
Premium
The Fly
CEL-SCI completes Breakthrough Medicine Designation application for Multikine
2M ago
CEL-SCI announces neoadjuvant nivolumab plus chemotherapy study published
PremiumThe FlyCEL-SCI announces neoadjuvant nivolumab plus chemotherapy study published
4M ago
CEL-SCI to initiate Multikine cancer trial
Premium
The Fly
CEL-SCI to initiate Multikine cancer trial
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
7M ago
CEL-SCI files to sell 1M shares of common stock for holders
PremiumThe FlyCEL-SCI files to sell 1M shares of common stock for holders
9M ago
CEL-SCI announces potential impact on Multikine following FDA ODAC meeting
Premium
The Fly
CEL-SCI announces potential impact on Multikine following FDA ODAC meeting
9M ago
CEL-SCI selects Ergomed as CRO for Multikine registration trial
Premium
The Fly
CEL-SCI selects Ergomed as CRO for Multikine registration trial
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100